参考文献
[ 1 ] Sasaki Y,Kakita H,Kubota S,et al. SARM1 depletion rescues NMNAT1-dependent photoreceptor cell death and retinal degeneration[J]. Elife,2020(9):e62027.
[ 2 ] Gerdts J,Summers DW,Sasaki Y,et al. Sarm1-mediated axon degeneration requires both SAM and TIR interactions[J]. Journal of Neuroscience,2013,33(33):13569-13580.
[ 3 ] Murata H,Khine CC,Nishikawa A,et al. C-Jun N-terminal kinase (JNK)-mediated phosphorylation of SARM1 regulates NAD+ cleavage activity to inhibit mitochondrial respiration[J]. Journal of Biological Chemistry,2018,293(49):18933-18943.
[ 4 ] Liu Huitao,Zhang Jingjing,Xu Xingxing et al. SARM1 promotes neuroinflammation and inhibits neural regeneration after spinal cord injury through NF-κB signaling[J]. Theranostics,2021(11):4187-4206.
[ 5 ] Luo Lin,Lucas Richard M,Liu Liping et al. Signalling, sorting and scaffolding adaptors for Toll-like receptors[J]. J Cell Sci,2020(133):140.
[ 6 ] Angeletti Carlo,Amici Adolfo,Gilley Jonathan et al. SARM1 is a multi-functional NAD(P)ase with prominent base exchange activity,all regulated bymultiple physiologically relevant NAD metabolites[J].iScience,2022(25):103-812.
[ 7 ] Morale Mirian Galliote,da Silva Abjaude Walason,Silva Aline Montenegro et al. HPV-transformed cells exhibit altered HMGB1-TLR4/MyD88-SARM1 signaling axis[J]. Sci Rep,2018(8): 3476.
[ 8 ] Li Yihang,Pazyra-Murphy Maria F,Avizonis Daina et al. Sarm1 activation produces cADPR to increase intra-axonal Ca2+ and promote axon degeneration in PIPN[J]. J Cell Biol,2022(7): 221-234.
[ 9 ] Wang J,Zhai Q,Chen Y,et al. A local mechanism mediates NAD+ dependent protection of axon degeneration[J]. The Journal of Cell Biology,2005,170(3):349-355.
[10] Vargas ME,Yamagishi Y,Tessier-Lavigne M,et al. Live imaging of calcium dynamics during axon degeneration reveals two functionally distinct phases of calcium influx[J]. Journal of Neuroscience,2015,35(45):15026-15038.
[11] Chuang CF,Bargmann CI. A Toll-interleukin 1 repeat protein at the synapse specifies asymmetric odorant receptor expression via ASK1 MAPKKK signaling[J]. Genes & Development, 2005,19(2):270-281.
[12] Hsu JM,Kang Y,Corty MM, et al. Injury-induced inhibition of bystander neurons requires dSarm and signaling from glia[J]. Neuron,2021,109(3):473-487.
[13] Yang J,Wu Z,Renier N,et al. Pathological axonal death through a MAPK cascade that triggers a local energy deficit[J]. Cell,2015(160):161-176.
[14] Miller BR,Press C,Daniels RW,et al. A dual leucine kinase-dependent axon self-destruction program promotes Wallerian degeneration[J]. Nature Neuroscience,2009,12(4): 387-389.
[15] Walker LJ,Summers DW,Sasaki Y,et al. MAPK signaling promotes axonal degeneration by speeding the turnover of the axonal maintenance factor NMNAT2[J]. Elife, 2017(6):e22540.
[16] Lu Qicheng,Botchway Benson OA,Zhang Yong et al. SARM1 can be a potential therapeutic target for spinal cord injury[J]. Cell Mol Life Sci,2022(79):161.
[17] Essuman K,Summers DW,Sasaki Y,et al. The SARM1 toll/interleukin-1 receptor domain possesses intrinsic NAD+ cleavage activity that promotes pathological axonal degeneration[J]. Neuron,2017,93(6):1334-1343.
|